Astrana Health Stock Working Capital

ASTH Stock

33.48 0.01 0.03%

Astrana Health fundamentals help investors to digest information that contributes to Astrana Health's financial success or failures. It also enables traders to predict the movement of Astrana Stock. The fundamental analysis module provides a way to measure Astrana Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Astrana Health stock.

	Last Reported	Projected for Next Year
Net Working Capital	242.8 M	219.5 M
Change In Working Capital	-23.4 M	-22.2 M

The current Net Working Capital is estimated to decrease to about 219.5 M. The Astrana Health's current Change In Working Capital is estimated to increase to about (22.2 M).

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Astrana Health Company Working Capital Analysis

Astrana Health's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Working Capital

Current Assets

-

Current Liabilities

More About Working Capital | All Equity Analysis

Current Astrana Health Working Capital

242.83 M

Most of Astrana Health's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Astrana Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Astrana Working Capital Driver Correlations

Understanding the fundamental principles of building solid financial models for Astrana Health is extremely important. It helps to project a fair market value of Astrana Stock properly, considering its historical fundamentals such as Working Capital. Since Astrana Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Astrana Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Astrana Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Common Stock	Short Term Debt	Net Receivables	Net Tangible Assets	Current Deferred Revenue	Long Term Debt	Good Will	Short Term Investments	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Intangible Assets	Property Plant Equipment	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.94	0.12	0.86	0.55	0.96	0.99	0.48	0.73	0.94	0.87	0.45	0.91	0.94	0.44	0.9	0.96	0.51	0.85	0.85	0.42	0.75	0.89	0.94	0.82
Total Stockholder Equity	0.94		0.05	0.97	0.45	0.96	0.97	0.48	0.78	0.96	0.96	0.25	0.89	0.81	0.19	0.87	0.99	0.29	0.66	0.97	0.52	0.63	0.93	0.89	0.93
Net Debt	0.12	0.05		0.09	-0.31	0.29	0.2	0.05	0.44	0.22	-0.07	0.19	0.48	0.05	0.68	0.5	0.04	0.29	-0.02	0.09	0.49	-0.18	0.23	0.28	0.11
Retained Earnings	0.86	0.97	0.09		0.32	0.92	0.91	0.49	0.79	0.94	0.95	0.11	0.86	0.69	0.08	0.83	0.95	0.17	0.5	0.99	0.59	0.47	0.91	0.83	0.95
Accounts Payable	0.55	0.45	-0.31	0.32		0.47	0.46	0.15	0.4	0.36	0.38	0.05	0.3	0.61	0.1	0.3	0.51	0.05	0.73	0.35	0.21	0.55	0.3	0.29	0.28
Total Liab	0.96	0.96	0.29	0.92	0.47		0.99	0.47	0.86	0.97	0.87	0.33	0.97	0.85	0.42	0.96	0.96	0.41	0.73	0.91	0.6	0.62	0.92	0.92	0.88
Total Current Assets	0.99	0.97	0.2	0.91	0.46	0.99		0.49	0.78	0.97	0.89	0.41	0.95	0.89	0.42	0.94	0.98	0.46	0.77	0.9	0.48	0.68	0.93	0.96	0.87
Common Stock	0.48	0.48	0.05	0.49	0.15	0.47	0.49		0.28	0.45	0.46	0.16	0.46	0.51	0.18	0.45	0.48	0.14	0.38	0.44	0.21	0.02	0.55	0.51	0.52
Short Term Debt	0.73	0.78	0.44	0.79	0.4	0.86	0.78	0.28		0.81	0.74	0.08	0.84	0.57	0.26	0.81	0.79	0.23	0.48	0.8	0.88	0.42	0.72	0.63	0.75
Net Receivables	0.94	0.96	0.22	0.94	0.36	0.97	0.97	0.45	0.81		0.91	0.29	0.93	0.82	0.33	0.91	0.96	0.45	0.68	0.93	0.54	0.6	0.91	0.91	0.87
Net Tangible Assets	0.87	0.96	-0.07	0.95	0.38	0.87	0.89	0.46	0.74	0.91		0.16	0.79	0.74	0.0	0.75	0.95	0.29	0.59	0.95	0.5	0.64	0.85	0.79	0.89
Current Deferred Revenue	0.45	0.25	0.19	0.11	0.05	0.33	0.41	0.16	0.08	0.29	0.16		0.39	0.53	0.71	0.42	0.3	0.71	0.55	0.04	-0.14	0.6	0.31	0.53	0.16
Long Term Debt	0.91	0.89	0.48	0.86	0.3	0.97	0.95	0.46	0.84	0.93	0.79	0.39		0.79	0.55	1.0	0.89	0.44	0.65	0.85	0.6	0.53	0.92	0.94	0.84
Good Will	0.94	0.81	0.05	0.69	0.61	0.85	0.89	0.51	0.57	0.82	0.74	0.53	0.79		0.51	0.79	0.85	0.57	0.94	0.67	0.25	0.76	0.81	0.87	0.71
Short Term Investments	0.44	0.19	0.68	0.08	0.1	0.42	0.42	0.18	0.26	0.33	0.0	0.71	0.55	0.51		0.59	0.22	0.66	0.55	0.04	0.1	0.29	0.32	0.54	0.09
Long Term Debt Total	0.9	0.87	0.5	0.83	0.3	0.96	0.94	0.45	0.81	0.91	0.75	0.42	1.0	0.79	0.59		0.87	0.44	0.65	0.82	0.56	0.53	0.91	0.94	0.82
Capital Surpluse	0.96	0.99	0.04	0.95	0.51	0.96	0.98	0.48	0.79	0.96	0.95	0.3	0.89	0.85	0.22	0.87		0.34	0.72	0.94	0.51	0.69	0.91	0.89	0.91
Deferred Long Term Liab	0.51	0.29	0.29	0.17	0.05	0.41	0.46	0.14	0.23	0.45	0.29	0.71	0.44	0.57	0.66	0.44	0.34		0.65	0.13	0.0	0.61	0.26	0.49	0.1
Intangible Assets	0.85	0.66	-0.02	0.5	0.73	0.73	0.77	0.38	0.48	0.68	0.59	0.55	0.65	0.94	0.55	0.65	0.72	0.65		0.49	0.18	0.79	0.59	0.71	0.47
Property Plant Equipment	0.85	0.97	0.09	0.99	0.35	0.91	0.9	0.44	0.8	0.93	0.95	0.04	0.85	0.67	0.04	0.82	0.94	0.13	0.49		0.59	0.48	0.91	0.82	0.94
Short Long Term Debt	0.42	0.52	0.49	0.59	0.21	0.6	0.48	0.21	0.88	0.54	0.5	-0.14	0.6	0.25	0.1	0.56	0.51	0.0	0.18	0.59		0.05	0.47	0.33	0.54
Long Term Investments	0.75	0.63	-0.18	0.47	0.55	0.62	0.68	0.02	0.42	0.6	0.64	0.6	0.53	0.76	0.29	0.53	0.69	0.61	0.79	0.48	0.05		0.52	0.63	0.46
Net Invested Capital	0.89	0.93	0.23	0.91	0.3	0.92	0.93	0.55	0.72	0.91	0.85	0.31	0.92	0.81	0.32	0.91	0.91	0.26	0.59	0.91	0.47	0.52		0.94	0.96
Net Working Capital	0.94	0.89	0.28	0.83	0.29	0.92	0.96	0.51	0.63	0.91	0.79	0.53	0.94	0.87	0.54	0.94	0.89	0.49	0.71	0.82	0.33	0.63	0.94		0.84
Capital Stock	0.82	0.93	0.11	0.95	0.28	0.88	0.87	0.52	0.75	0.87	0.89	0.16	0.84	0.71	0.09	0.82	0.91	0.1	0.47	0.94	0.54	0.46	0.96	0.84

Click cells to compare fundamentals

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.

Competition

Predict Astrana Health

Working Capital Over Time

Astrana Capital Surpluse

Capital Surpluse

434.82 Million

As of now, Astrana Health's Capital Surpluse is increasing as compared to previous years.

In accordance with the company's disclosures, Astrana Health has a Working Capital of 242.83 M. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The working capital for all United States stocks is notably lower than that of the firm.

Astrana Working Capital Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Astrana Health's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Astrana Health could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics of similar companies.

Astrana Health is currently under evaluation in working capital category among its peers.

Astrana Health ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Astrana Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Astrana Health's managers, analysts, and investors.

Environmental

Governance

Social

Astrana Fundamentals

	Return On Equity	0.1
	Return On Asset	0.0449
	Profit Margin	0.04 %
	Operating Margin	0.06 %
	Current Valuation	1.65 B
	Shares Outstanding	45.65 M
	Shares Owned By Insiders	23.60 %
	Shares Owned By Institutions	45.99 %
	Number Of Shares Shorted	1.64 M
	Price To Book	2.17 X
	Price To Sales	0.89 X
	Revenue	1.39 B
	Gross Profit	199.48 M
	EBITDA	123.69 M
	Net Income	57.85 M
	Total Debt	321.01 M
	Book Value Per Share	14.75 X
	Cash Flow From Operations	68.23 M
	Short Ratio	4.86 X
	Earnings Per Share	1.30 X
	Target Price	64.5
	Number Of Employees	1.8 K
	Beta	1.24
	Market Capitalization	1.53 B
	Total Asset	933.36 M
	Retained Earnings	243.13 M
	Working Capital	242.83 M
	Net Asset	933.36 M

About Astrana Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Astrana Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Astrana Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Astrana Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether Astrana Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Astrana Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrana Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrana Health Stock:

How To Invest In Astrana

Details

Is Astrana Stock a good investment?

Details

What is Astrana Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Astrana Health Piotroski F Score and Astrana Health Altman Z Score analysis.

For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.30)

Earnings Share

1.3

Revenue Per Share

36.415

Quarterly Revenue Growth

0.375

Return On Assets

0.0449

The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Astrana Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Astrana Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astrana Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Astrana Health Stock Working Capital

Astrana Health Company Working Capital Analysis

Working Capital

Current Assets

-

Current Liabilities

Current Astrana Health Working Capital

Astrana Working Capital Driver Correlations

Astrana Capital Surpluse

Capital Surpluse

434.82 Million

Astrana Working Capital Peer Comparison

Astrana Health ESG Sustainability

Astrana Fundamentals

About Astrana Health Fundamental Analysis

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY